Literature DB >> 28107895

Psychological distress longitudinally mediates the effect of vertigo symptoms on vertigo-related handicap.

Thomas Probst1, Andreas Dinkel2, Gabriele Schmid-Mühlbauer3, Katharina Radziej4, Karina Limburg5, Christoph Pieh6, Claas Lahmann7.   

Abstract

OBJECTIVE: Vertigo symptoms can lead to more or less vertigo-related handicap. This longitudinal study investigated whether depression, anxiety, and/or somatization mediate the relationship between vertigo symptoms and vertigo-related handicap.
METHODS: N=111 patients with vertigo/dizziness provided complete data on the following measures: Vertigo symptoms at baseline, depression at 6-month follow-up, anxiety at 6-month follow-up, somatization at 6-month follow-up, and vertigo handicap at 12-month follow-up. Mediation analyses with bootstrapping were performed to investigate the mediating role of anxiety, depression, and somatization in the relationship between vertigo symptoms and vertigo-related handicap.
RESULTS: When the mediating role of anxiety, depression, and somatization was evaluated separately from each other in single mediation models, the effect vertigo symptoms at baseline exerted on vertigo-related handicap at 12-month follow-up was significantly mediated by depression at 6-month follow-up (p<0.05), by anxiety at 6-month follow-up (p<0.05), as well as by somatization at 6-month follow-up (p<0.05). When statistically controlling for the other mediators in a multiple mediator model, only depression at 6-month follow-up mediated the effect of vertigo symptoms at baseline on vertigo-related handicap at 12-month follow-up (p<0.05).
CONCLUSION: Psychological distress is an important mechanism in the process how vertigo symptoms lead to vertigo-related handicap.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Dizziness; Somatization; Vertigo

Mesh:

Year:  2016        PMID: 28107895     DOI: 10.1016/j.jpsychores.2016.11.013

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  5 in total

1.  Assessment of Potential Risk Factors for the Development of Persistent Postural-Perceptual Dizziness: A Case-Control Pilot Study.

Authors:  Aaron Trinidade; Paula Harman; Jon Stone; Jeffrey P Staab; Joel A Goebel
Journal:  Front Neurol       Date:  2021-01-21       Impact factor: 4.003

2.  Prevalence, etiology, and biopsychosocial risk factors of cervicogenic dizziness in patients with neck pain: A multi-center, cross-sectional study.

Authors:  Meltem Vural; Ayşe Karan; İlknur Albayrak Gezer; Ahmet Çalışkan; Sevgi Atar; Filiz Yıldız Aydın; İlke Coşkun Benlidayı; Aylin Gökşen; Şebnem Koldaş Doğan; Gülçin Karacan; Rana Erdem; Emine Eda Kurt; Fatma Nur Kesiktaş; Tuğba Aydın; Nilay Şahin; Zafer Aydın; Banu Ordahan; Gözde Türkoğlu; Hatice Reşorlu; Davut Döner; Figen Yılmaz; Hüseyin Bertan; Deniz Dülgeroğlu; Özgür Zeliha Karaahmet; Birkan Sonel Tur; Esra Moustafa; Pınar Borman; Öner İskender; Saime Ay; Aydan Kurtaran; Hülya Şirzai; Deniz Evcik; Nalan Çapan; Belgin Erhan; Hasan Kerem Alptekin; Halil İbrahim Ural
Journal:  Turk J Phys Med Rehabil       Date:  2021-12-01

3.  What Predicts Improvement of Dizziness after Multimodal and Interdisciplinary Day Care Treatment?

Authors:  Tino Prell; Sigrid Finn; Hannah M Zipprich; Hubertus Axer
Journal:  J Clin Med       Date:  2022-04-03       Impact factor: 4.241

4.  A Randomized Controlled Trial Evaluating Integrative Psychotherapeutic Group Treatment Compared to Self-Help Groups in Functional Vertigo/Dizziness.

Authors:  Karina Limburg; Katharina Radziej; Heribert Sattel; Peter Henningsen; Marianne Dieterich; Thomas Probst; Rachel Dale; Claas Lahmann
Journal:  J Clin Med       Date:  2021-05-20       Impact factor: 4.241

5.  The Role of Prediagnosis Audiovestibular Dysfunction Versus Distress, Illness-Related Cognitions, and Behaviors in Predicted Ongoing Dizziness Handicap.

Authors:  David Herdman; Sam Norton; Marousa Pavlou; Louisa Murdin; Rona Moss-Morris
Journal:  Psychosom Med       Date:  2020-10       Impact factor: 3.864

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.